During the past decade, Renew Health Clinical Research, LLC conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Renew Health Clinical Research, LLC" are "Major Depressive Disorder" (1 trials), "Migraine" (1 trials), "Obsessive Compulsive Disorder" (1 trials) and "Obsessive-Compulsive Disorder" (1 trials). Many other conditions were trialed in "Renew Health Clinical Research, LLC" in a lesser frequency.

Most popular intervention types in "Renew Health Clinical Research, LLC" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Rimegepant" (1 trials), "Troriluzole" (1 trials), "Troriluzole (BHV-4157)" (1 trials) and "tDCS intervention applied by Starstim device" (1 trials). Other intervention names were less common.

The vast majority of trials in "Renew Health Clinical Research, LLC" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Renew Health Clinical Research, LLC". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in Renew Health Clinical Research, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Renew Health Clinical Research, LLC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".